WHO ICTRP trial

Evaluation of the efficacy of the detection of the significant cancer and the…

JPRN-UMIN000042397 · Japan Primary Registries Network (JPRN) · Not Recruiting

Key facts

Trial ID JPRN-UMIN000042397
Public title Evaluation of the efficacy of the detection of the significant cancer and the safety in MRI-TRUS fusion image-guided prostate biopsy: multi-institutional study in Japan
Scientific title Evaluation of the efficacy of the detection of the significant cancer and the safety in MRI-TRUS fusion image-guided prostate biopsy: multi-institutional study in Japan - Evaluation of the efficacy of the detection of the significant cancer and the safety in MRI-TRUS fusion image-guided prostate…
Primary sponsor Tokai University
Secondary sponsors Kanazawa Medical University, Saiseikai Kawaguchi General Hospital, Nagoya City University, The Jikei University School of Medicine, Okayama University, Juntendo University, KKR Takamatsu Hospital…
Registry Japan Primary Registries Network (JPRN)
Recruitment status Not Recruiting
Study type Observational
Phase Not selected
Countries Japan
Conditions prostate cancer suspected
Registration date Sep 11, 2020
Target size 400
Registry page center6.umin.ac.jp

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations